Veterinary pharmacovigilance monitors the safety of veterinary medicines, including vaccines, used for the prophylaxis, diagnosis or treatment of disease in animals once they reach the market after authorization. The task of veterinary pharmacovigilance is to ensure

This can only be achieved if all observed adverse events, either by veterinarian, animal keeper or pet owner, are reported to the national competent authorities or to the marketing authorization holder of the veterinary medicine. The following observations are considered to be adverse events:

All adverse events can be reported to Huvepharma by e-mail ( or to your national competent authority.